MY174063A - Poly-l-glutamic acid drug carrier for targeting and treating kidney diseases - Google Patents

Poly-l-glutamic acid drug carrier for targeting and treating kidney diseases

Info

Publication number
MY174063A
MY174063A MYPI2015703572A MYPI2015703572A MY174063A MY 174063 A MY174063 A MY 174063A MY PI2015703572 A MYPI2015703572 A MY PI2015703572A MY PI2015703572 A MYPI2015703572 A MY PI2015703572A MY 174063 A MY174063 A MY 174063A
Authority
MY
Malaysia
Prior art keywords
targeting
poly
drug carrier
glutamic acid
kidney diseases
Prior art date
Application number
MYPI2015703572A
Inventor
Dr Chung Lip Yong Prof
Kiew Lik Voon Dr
Dr Nor Azizan Bt Abdullah Prof
Chai Hann Juang Mr
Original Assignee
Univ Of Malaya
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Of Malaya filed Critical Univ Of Malaya
Priority to MYPI2015703572A priority Critical patent/MY174063A/en
Publication of MY174063A publication Critical patent/MY174063A/en

Links

Landscapes

  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)

Abstract

The present invention disclosed a renal targeting drug carrier for treating renal impairment. The renal targeting drug carrier consists of poly-L-glutamic acid, PG for targeting and treating kidney diseases. Besides, a method (10) to produce a renal targeting drug carrier consists of poly-L-glutamic acid, PG conjugated with renal protecting drug is also disclosed in the present invention.
MYPI2015703572A 2015-10-07 2015-10-07 Poly-l-glutamic acid drug carrier for targeting and treating kidney diseases MY174063A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
MYPI2015703572A MY174063A (en) 2015-10-07 2015-10-07 Poly-l-glutamic acid drug carrier for targeting and treating kidney diseases

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MYPI2015703572A MY174063A (en) 2015-10-07 2015-10-07 Poly-l-glutamic acid drug carrier for targeting and treating kidney diseases

Publications (1)

Publication Number Publication Date
MY174063A true MY174063A (en) 2020-03-06

Family

ID=79646165

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI2015703572A MY174063A (en) 2015-10-07 2015-10-07 Poly-l-glutamic acid drug carrier for targeting and treating kidney diseases

Country Status (1)

Country Link
MY (1) MY174063A (en)

Similar Documents

Publication Publication Date Title
MX2020011783A (en) Combination therapy involving antibodies against claudin 18.2 for treatment of cancer.
CL2015003731A1 (en) Bromodomain Inhibitors
JO3522B1 (en) Pharmaceutical composition comprising erythrocytes encapsulating a PLP-dependent enzyme and its cofactor
PH12018501227A1 (en) Drug for preventing and/or treating polycystic kidney disease
MX2016002544A (en) Compounds useful as immunomodulators.
NZ739133A (en) Cellular targeted active ingredient delivery system
TW201613636A (en) Methods of treating Alzheimer's Disease
MX2015009106A (en) Solid solution compositions and use in severe pain.
MX2015011606A (en) Methods of treating cancer and preventing cancer drug resistance.
MX2015010791A (en) Methods of treating cancer and preventing drug resistance.
MX2016005669A (en) Alginate coating for sett treatment.
BR112019001398A2 (en) Methods for Prostate Cancer Treatment
AU2018253600A1 (en) Dosage forms and therapeutic uses of l-4-chlorokynurenine
MX2019015676A (en) Use of isovalerylspiramycin i, ii and/or iii in preparation of drug for treating and/or preventing tumour, and drug.
MX2017000306A (en) Methods for treating hypotension.
MY200161A (en) Bacteria for targeting tumors and treating cancer
GB201302343D0 (en) Pharmaceutical compositions comprising 15-OHEPA and methods for using the same
SG10201811078XA (en) Method Of Treatment Of Hypoxia Inducible Factor (HIF)-Related Conditions
MX2018005085A (en) Therapeutic nanoparticles comprising a therapeutic agent and methods of making and using same.
MX2019001634A (en) Amide compounds, pharmaceutical compositions thereof, and methods of using the same.
PH12018501624A1 (en) A composition comprising pic for treatment of cancer
MX2016002307A (en) Cancer treatment.
MX2019014291A (en) Treatment method.
PH12017501979A1 (en) Pharmaceutical compound
MY174063A (en) Poly-l-glutamic acid drug carrier for targeting and treating kidney diseases